Korean Journal of Clinical Laboratory Science (대한임상검사과학회지)

Korean Society for Clinical Laboratory Science (대한임상검사과학회)
권호 표지
DOI QR코드

DOI QR Code

Evaluation of p16INK4a/Ki-67 Dual Immunostaining in Liquid-based Cytology for Diagnosis of Uterine Cervical Dysplasia and Cancer

자궁경부 이형성증과 암의 진단을 위한 액상세포 검체에서 p16INK4a/Ki-67 이중면역염색의 평가

  • Sung, Mi Hee (Department of Pathology, Konkuk University Medical Center) ;
  • Lee, Hoon Taek (Department of Animal Biotechnology, Konkuk University) ;
  • Shin, Min Shik (Department of Pathology, Konkuk University Medical Center) ;
  • Oh, Seo Young (Department of Pathology, Konkuk University Medical Center) ;
  • Kim, Wook Youn (Department of Pathology, Konkuk University Medical Center)
  • 성미희 (건국대학교병원 병리과) ;
  • 이훈택 (건국대학교 동물생명공학과) ;
  • 신민식 (건국대학교병원 병리과) ;
  • 오서영 (건국대학교병원 병리과) ;
  • 김욱연 (건국대학교병원 병리과)
  • Received : 2015.06.09
  • Accepted : 2015.07.20
  • Published : 2015.09.30
Download PDF
⟨ Previous Next ⟩

Abstract

Recently, $p16^{INK4a}$/Ki-67 dual immunostaining has been introduced as a new biomarker protocol for early detection of uterine cervical dysplasia and cancer in liquid-based cytology (LBC). We performed the $p16^{INK4a}$/Ki-67 dual immunostaining using a CINtec$^{(R)}$ PLUS kit in a total of 109 LBC cases of cervicovaginal smear and compared its results with those from LBC, HPV hybrid capture II (HC II) test and histological diagnosis. Expression of $p16^{INK4a}$ and Ki-67 was significantly associated with cases of LSIL or higher in cytological diagnosis and cases of cervical intraepithelial neoplasia (CIN) 1 or higher in histological diagnosis (p<0.001 and p<0.001, respectively). Among forty-six cases of atypical squamous cells of undetermined significance (ASCUS) in LBC, $p16^{INK4a}$ and Ki-67 was expressed in 31 (67.4%), which were positively associated with cases of CIN I lesion or higher in histology. The sensitivity of $p16^{INK4a}$/Ki-67 dual immunostaining for finding lesions of CIN 1 or higher was 89.0%, which was higher than LBC. The specificity was 73.5%, which was higher than that of the HC II test. Based on these results, the $p16^{INK4a}$/Ki-67 dual immunostaining method can be a useful diagnostic marker for improving the sensitivity of LBC and the specificity of HC II test.

최근 $p16^{INK4a}$/Ki-67 이중면역염색은 액상세포검사에서 자궁경부 이형성증과 암을 조기에 발견하기 위한 새로운 생체 표지자로 대두되고 있다. 저자들은 자궁경부질도말의 액상세포검체 총 109례에서 CINtec$^{(R)}$ PLUS kit를 사용하여 $p16^{INK4a}$/Ki-67 이중면역염색을 시행하였고, 그 결과를 액상세포검사, HPV hybrid capture II (HC II) 검사 그리고 조직학적 진단과 서로 비교하였다. $p16^{INK4a}$/Ki-67 양성 발현은 세포학적 진단에서 저등급 편평상피내병변 이상의 증례 그리고 조직학적 진단에서 자궁경부 상피내종양 1등급 이상의 증례에서 유의미하게 높았다. 액상세포검사상 비정형 편평 상피세포 소견을 보이는 46례 중, 31례 (67.4%)가 $p16^{INK4a}$과 Ki-67 양성 소견을 보였고, 이러한 양성 증례들은 조직검사에서도 대부분 자궁경부 상피내종양 1등급 이상의 병변에 해당하였다. 자궁경부 상피내종양 1등급 이상의 병변을 발견하기 위한 $p16^{INK4a}$/Ki-67 이중면역염색의 민감도는 액상세포검사보다 높은 89.0%였고, 특이도는 73.5%로 HC II 검사보다 높게 분석되었다. 따라서, $p16^{INK4a}$/Ki-67 이중면역염색 방법은 액상세포검사법의 민감도와 HC II 검사법의 특이도를 보완하기 위한 진단적 검사로 유용하다고 할 수 있다.

Keywords

References

  1. Byun SW, Lee A, Kim S, Choi YJ, Lee YS, Park JS. Immunostaining of $p16^{INK4a}$ /Ki-67 and L1 capsid protein on liquid-based cytology specimens obtained from ASC-H and LSIL-H cases. Int J Med Sci. 2013, 10:1602-1607. https://doi.org/10.7150/ijms.6526
  2. Choi SK, Kim TJ, Hong SB, Lee HT. Expression of p53 and Ki-67 in cervical dysplasia with human papilloma virus infection or non-infection. Korean J Clin Lab Sci. 2004, 36(2):178-184.
  3. Dona MG, Vocaturo A, Giuliani M, Ronchetti L, Rollo F, Pescarmona E, et al. p16/ Ki-67 dual staining in cervico-vaginal cytology: correlation with histology, Human Papillomavirus detection and genotyping in women undergoing colposcopy. Gynecol Onocol. 2012, 126:198-202. https://doi.org/10.1016/j.ygyno.2012.05.004
  4. Edgerton N, Cohen C, Siddiqui MT. Evaluation of CINtec PLUS Testing as an adjunctive test in ASC-US diagnosed Surepath preparations. Diagn Cytopathol. 2013, 41: 35-40. https://doi.org/10.1002/dc.21757
  5. Ikenberg H, Bergeron C, Schmidt D, Griesser H, Alameda F, Angeloni C, et al. Screening for cervical cancer precursors with p16/Ki-67 dual-stained cytology: results of the PALMS study. J Natl Cancer Inst. 2013, 105:1550-1557. https://doi.org/10.1093/jnci/djt235
  6. Keating JT, Ince T, Crum CP. Surrogate biomarkers of HPV infection in cervical neoplasia screening and diagnosis. Adv Anat Pathol. 2001, 8:83-92. https://doi.org/10.1097/00125480-200103000-00004
  7. Keating JT, Cviko A, Riethdorf, Riethdrof L, Quade BJ, Sun D, et al. Ki-67, cyclin E, and p16INK4 are complimentary surrogate biomarkers for human papilloma virus-related cervical neoplasia. Am J Surg Pathol. 2001, 25:884-891. https://doi.org/10.1097/00000478-200107000-00006
  8. Kim MY, Cho SH, Park MH. Analysis of expression of p63 incervical neoplasia comparing with other immunohistochemical markers. Korean J Pathol. 2003, 37:333-341.
  9. Klaes R, Friedrich T, Spitkovsky D, Ridder R, Rudy W, Petry U, et al. Overexpression of p16(INK4a) as a specific marker for dysplastic and neoplastic epithelial cells of the cervix uteri. Int J Cancer. 2001, 92:276-284. https://doi.org/10.1002/ijc.1174
  10. Kruse AJ, Jansen EA, Kjellevold KH, Lovesiett K, Bergh J, Bergh J, et al. Ki-67 predicts progression in early CIN. Validation of a multivariate progression risk mode. Cell Oncol. 2004, 26:13-20.
  11. Kwon MJ, Song EJ, Kim CW, Hong SN, Eum ST. The significance of Human Papilloma viral load by using hybrid capture II assay in diagnosis of CIN II or above in women with PAP smear showing only ASCUS/LSIL. Obstet Gynecol Sci. 2005, 12: 2867-2876.
  12. Lee KO, Seong HS, Chung SJ, Jung NY, Lee HJ, Kim KT. Genotype Frequency of Human Papillomavirus Determined by PCR and DNA Sequencing in Korean Women. Korean J Clin Lab Sci. 2006, 27(2):99-105.
  13. Lim HS, Kim MJ, Park KE, Chung HH, Park NH, Song YS, et al. The efficacy of a real-time optoelectronic device as a diagnostic tool of over cervical intraepithelial neoplasia 1 lesion. Obstet Gynecol Sci. 2010, 10:888-89.
  14. National cancer center. Annual report of cancer statistics in Korea in 2011 [Internet]. Available from: http://www.cancer.go.kr/cms/statics/incidence/index. html, last visited on 2014 January 26.
  15. Nucci MR, Castrillon DH, Bai H, Quade BJ, Ince TA, Genest DR, et al. Biomarkers in diagnostic obstetric and gynecologic pathology: A review. Adv Anat Pathol. 2003, 10: 55-68. https://doi.org/10.1097/00125480-200303000-00001
  16. Overstad IT, Vennestrom U, Andersen L, Gudlaugsson E, Munk AC, Malpica A, et al. Comparison of different commercial methods for HPV detection in follow upbiopsies and spontaneous regression of CIN 2-3. Gynecol Oncol. 2011, 123:278-283. https://doi.org/10.1016/j.ygyno.2011.07.024
  17. Petry KU, Schmidt D, Scherbring S, Luyten A, Reinecke-Luthge A, Bergeron C, et al. Triaging pap cytology negative, HPV positive cervical cancer screening results with p16/Ki-67 Dualstained cytology. Gynecol Oncol. 2011, 121:505-509. https://doi.org/10.1016/j.ygyno.2011.02.033
  18. Reuschenbach M, Clad A, von Knebel Doeberitz C, Wentzensen N, Rahmsdorf J, Schaffrath F, et al. Performance of $p16^{INK4a}$-cytology, HPV mRNA, and HPV DNA testing to identify high grade cervical dysplasia I women with abnormal screening results. Gynecol Oncol. 2010, 199: 98-105.
  19. Sano T, Oyama T, Kashiwabara K, Fukuda T, Nakajima T. Expression status of p16 protein is associated with human papillomavirus oncogenic potential in cervical and genital lesions. Am J Pathol. 1998, 153:1741-1748. https://doi.org/10.1016/S0002-9440(10)65689-1
  20. Schmidt D, Beraeron C, Denton KJ, Ridder R. p16/Ki-67 dual-stain cytology in the triage of ASCUS and LSIL papanicolaou cytology results from the European equivocal or midly abnormal Papanicolaou cytolgy study. Cancer Cytopathol. 2011, 119:158-166. https://doi.org/10.1002/cncy.20140
  21. Stanley MA. Prognostic factors and new therapeutic approaches to cervical cancer. Virus Res. 2002, 89:241-248. https://doi.org/10.1016/S0168-1702(02)00192-2
  22. Stoler MH, Schiffman M. Interobsever reproducibility of cervical cytologic and histologic interpretations: realistic estimates from the ASCUS-LSIL triage study. JAMA. 2001, 285:1500-1505. https://doi.org/10.1001/jama.285.11.1500
  23. Szarewski A, Mesher D, Cadman L, Austin J, Ashdown-Barr L, Ho L, et al. Comparison of seven test for high-grade cervical intraepithelial neoplasia in women with abnormal smears. J Clin Microbiol. 2012, 50:1867-1873. https://doi.org/10.1128/JCM.00181-12
  24. Wentzensen N, Schwartz L, Zuna RE, Smith K, Mathews C, Gold MA, et al. Performance of p16/Ki-67 immunostaining to detect cervical cancer precursors in a colposcopy referral population. Clin Cancer Res. 2012, 18:4154-4162. https://doi.org/10.1158/1078-0432.CCR-12-0270
  25. Waldstrom M, Christensen RK, Omskov D. Evaluation of $p16^{INK4a}$/Ki-67 dual stain in comparison with an mRNA human papillomavirus test on liquid-based cytology samples with lowgrade squamous intraepithelial lesion. Cancer Cytopathol. 2013, 121:136-145. https://doi.org/10.1002/cncy.21233
  26. Yeo SJ, Nam KH, Shim IK, Kim TH, Lee KH, Kim HM, et al. Overexpression of $p16^{INK4a}$ as a biomarker for ASCUS in Thin PrepTM smear. J Gynecol Oncol. 2005, 16(2):141-147. https://doi.org/10.3802/kjgo.2005.16.2.141
  27. Yoshida T, Sano T, Kanuma T, Inoue H, Itoh T, Yazaki C, et al. Usefulness of $CINtec^{(R)}$ PLUS p16/Ki-67 double-staining in cytological screening of cervical cancer. Acta cytol. 2011, 55(5): 413-420. https://doi.org/10.1159/000331047
  28. Zappacosta R, Colasante A, Viola P, D' Antuono T, Lattanzio G, Capanna S, et al. Chromogenic in situ hybridization and p16/ Ki-67 dual staining on formalin-fixed paraffin-embedded cervical specimens: Correlation with HPV-DNA test, E6/E7 mRNA test, and potential clinical applications. Biomed Res Int. 2013, 2013:453-606.

Cited by

  1. 다발성골수종 환자의 파라핀포매조직에서 MicroRNA 발현 vol.47, pp.4, 2015, https://doi.org/10.15324/kjcls.2015.47.4.292